Okay, let's tackle this question. The patient has metastatic carcinoma and is on Fentanyl via a transdermal patch for severe pain. The question is asking what else he should be taking or have on hand.

First, I need to recall the management of opioid use, especially transdermal fentanyl. Transdermal patches provide continuous release, so they're for baseline pain control. But breakthrough pain is common. Breakthrough pain is usually managed with immediate-release opioids. So maybe the answer is an opioid like morphine sulfate or hydromorphone for breakthrough.

Wait, the options aren't listed here, but the correct answer in the original question isn't provided. Let me think. The options might include an opioid for breakthrough, an antiemetic, an antidiarrheal, or maybe a laxative. Common side effects of opioids include constipation, so a laxative like docusate or senna is often co-prescribed. Also, antiemetics like ondansetron might be used if he has nausea. But the key here is that transdermal fentanyl is a long-acting opioid, so he needs something for breakthrough pain. So the correct answer would be an immediate-release opioid. Let me check standard guidelines. Yes, NCCN guidelines recommend having an immediate-release opioid for breakthrough pain when using long-acting ones. So the answer is likely an opioid like morphine or oxycodone for breakthrough. The other options like antiemetics or laxatives are important but not the main answer here. So the correct answer is an opioid for breakthrough pain.

**Core Concept**
Transdermal fentanyl is a long-acting opioid used for chronic, severe pain (e.g., cancer). Patients on long-acting opioids require **immediate-release opioids** (e.g., morphine, oxycodone) to manage breakthrough pain episodes, as these act rapidly and predictably when baseline analgesia is insufficient.

**Why the Correct Answer is Right**
Fentanyl patches provide continuous analgesia over 72 hours but cannot address acute breakthrough pain due to their fixed release rate. Immediate-release opioids (e.g., **morphine sulfate**) are the standard for breakthrough pain, typically prescribed at 10–20% of the total daily opioid dose. This ensures rapid relief without over-sedation or respiratory depression.

**Why Each Wrong Option is Incorrect**
**Option A:** Antiemetics like ondansetron are used for nausea but not routinely required unless the patient experiences opioid-induced nausea.
**Option B:** Laxatives (e.g., senna) are essential for opioid-induced constipation but do not address acute pain.
**Option C:** Antidiarrheals are irrelevant unless the patient has diarrhea, which is not typical with opioids.

**Clinical Pearl / High-Yield Fact**
Always prescribe an **immediate-release opioid** alongside long-acting agents for breakthrough pain. Use the "1:5 rule": breakthrough dose = 10–20% of the total 24-hour long-acting opioid dose. Never rely solely on the transdermal patch for acute flares.

**Correct Answer: D. Morphine sulfate (immediate-release formulation)**

✓ Correct Answer: B. Docusate